XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Jan. 31, 2024   1,035        
Beginning balance at Jan. 31, 2024 $ 59,646 $ 1 $ (11,692) $ 59,841 $ (225) $ 11,721
Beginning balance (in shares) at Jan. 31, 2024     (64)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued (in shares)   7        
Common stock issued 352     352    
Common stock repurchased (in shares)     (7)      
Common stock repurchased (2,168)   $ (2,168)      
Stock-based compensation 753     753    
Other comprehensive income (loss), net of tax (45)       (45)  
Cash dividends and dividend equivalents declared (388)         (388)
Net income 1,533         1,533
Ending balance (in shares) at Apr. 30, 2024   1,042        
Ending balance at Apr. 30, 2024 59,683 $ 1 $ (13,860) 60,946 (270) 12,866
Ending balance (in shares) at Apr. 30, 2024     (71)      
Beginning balance (in shares) at Jan. 31, 2024   1,035        
Beginning balance at Jan. 31, 2024 59,646 $ 1 $ (11,692) 59,841 (225) 11,721
Beginning balance (in shares) at Jan. 31, 2024     (64)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss), net of tax (11)          
Net income 2,962          
Ending balance (in shares) at Jul. 31, 2024   1,047        
Ending balance at Jul. 31, 2024 57,633 $ 1 $ (18,182) 62,143 (236) 13,907
Ending balance (in shares) at Jul. 31, 2024     (89)      
Beginning balance (in shares) at Apr. 30, 2024   1,042        
Beginning balance at Apr. 30, 2024 59,683 $ 1 $ (13,860) 60,946 (270) 12,866
Beginning balance (in shares) at Apr. 30, 2024     (71)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued (in shares)   5        
Common stock issued 384     384    
Common stock repurchased (in shares)     (18)      
Common stock repurchased (4,322)   $ (4,322)      
Stock-based compensation 813     813    
Other comprehensive income (loss), net of tax 34       34  
Cash dividends and dividend equivalents declared (388)         (388)
Net income 1,429         1,429
Ending balance (in shares) at Jul. 31, 2024   1,047        
Ending balance at Jul. 31, 2024 57,633 $ 1 $ (18,182) 62,143 (236) 13,907
Ending balance (in shares) at Jul. 31, 2024     (89)      
Beginning balance (in shares) at Jan. 31, 2025   1,056        
Beginning balance at Jan. 31, 2025 61,173 $ 1 $ (19,507) 64,576 (266) 16,369
Beginning balance (in shares) at Jan. 31, 2025     (94)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued (in shares)   6        
Common stock issued 97     97    
Common stock repurchased (in shares)     (10)      
Common stock repurchased (2,692)   $ (2,692)      
Stock-based compensation 817     817    
Other comprehensive income (loss), net of tax 136       136  
Cash dividends and dividend equivalents declared (406)         (406)
Net income 1,541         1,541
Ending balance (in shares) at Apr. 30, 2025   1,062        
Ending balance at Apr. 30, 2025 60,666 $ 1 $ (22,199) 65,490 (130) 17,504
Ending balance (in shares) at Apr. 30, 2025     (104)      
Beginning balance (in shares) at Jan. 31, 2025   1,056        
Beginning balance at Jan. 31, 2025 61,173 $ 1 $ (19,507) 64,576 (266) 16,369
Beginning balance (in shares) at Jan. 31, 2025     (94)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive income (loss), net of tax 313          
Net income 3,428          
Ending balance (in shares) at Jul. 31, 2025   1,067        
Ending balance at Jul. 31, 2025 61,328 $ 1 $ (24,408) 66,701 47 18,987
Ending balance (in shares) at Jul. 31, 2025     (112)      
Beginning balance (in shares) at Apr. 30, 2025   1,062        
Beginning balance at Apr. 30, 2025 60,666 $ 1 $ (22,199) 65,490 (130) 17,504
Beginning balance (in shares) at Apr. 30, 2025     (104)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued (in shares)   5        
Common stock issued 427     427    
Common stock withheld related to net share settlement of equity awards (12)     (12)    
Common stock repurchased (in shares)     (8)      
Common stock repurchased (2,209)   $ (2,209)      
Stock-based compensation 796     796    
Other comprehensive income (loss), net of tax 177       177  
Cash dividends and dividend equivalents declared (404)         (404)
Net income 1,887         1,887
Ending balance (in shares) at Jul. 31, 2025   1,067        
Ending balance at Jul. 31, 2025 $ 61,328 $ 1 $ (24,408) $ 66,701 $ 47 $ 18,987
Ending balance (in shares) at Jul. 31, 2025     (112)